New drug enters human testing in fight against advanced cancers
Disease control
Recruiting now
This is a first-in-human study to test the safety, side effects, and best dose of a new investigational drug called BB-1709. It is for adults with advanced solid tumors that have spread or cannot be removed by surgery and have stopped responding to standard treatments. The study …
Phase: PHASE1 • Sponsor: Bliss Biopharmaceutical (Hangzhou) Co., Ltd • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC